Literature DB >> 18081813

Resection margins and R1 rates in pancreatic cancer--are we there yet?

C S Verbeke1.   

Abstract

The prognosis of pancreatic cancer is poor, even for those patients who undergo surgical resection. The rate of local recurrence is high, despite the fact that in most series complete ('R0') resection is reported to be achieved in the majority of patients. The discrepancy between pathological assessment and clinical outcome indicates that microscopic margin involvement (R1) is frequently underreported, and potential causes for this are discussed in this review. Special emphasis is given to the variation that exists between currently used dissection techniques and their impact on the assessment of the resection margins in pancreatoduodenectomy specimens.

Entities:  

Mesh:

Year:  2007        PMID: 18081813     DOI: 10.1111/j.1365-2559.2007.02935.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  63 in total

1.  Pancreatic adenocarcinoma.

Authors:  Margaret A Tempero; J Pablo Arnoletti; Stephen Behrman; Edgar Ben-Josef; Al B Benson; Jordan D Berlin; John L Cameron; Ephraim S Casper; Steven J Cohen; Michelle Duff; Joshua D I Ellenhorn; William G Hawkins; John P Hoffman; Boris W Kuvshinoff; Mokenge P Malafa; Peter Muscarella; Eric K Nakakura; Aaron R Sasson; Sarah P Thayer; Douglas S Tyler; Robert S Warren; Samuel Whiting; Christopher Willett; Robert A Wolff
Journal:  J Natl Compr Canc Netw       Date:  2010-09       Impact factor: 11.908

Review 2.  Retroperitoneal margin of the pancreaticoduodenectomy specimen: anatomic mapping for the surgical pathologist.

Authors:  Mahmoud A Khalifa; Vlad Maksymov; Corwyn Rowsell
Journal:  Virchows Arch       Date:  2008-12-06       Impact factor: 4.064

3.  Prognostic value of the lymph node ratio after resection of periampullary carcinomas.

Authors:  Shahid G Farid; Gavin A Falk; Daniel Joyce; Sricharan Chalikonda; R Matthew Walsh; Andrew M Smith; Gareth Morris-Stiff
Journal:  HPB (Oxford)       Date:  2012-11-19       Impact factor: 3.647

4.  [New S3 guidelines on exocrine pancreatic cancer].

Authors:  A Tannapfel
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

5.  Pancreaticoduodenal resection for malignancy in a low-volume center: long-term outcomes from a developing country.

Authors:  Abu Bakar Hafeez Bhatti; Mohammad Aasim Yusuf; Syed Ather Saeed Kazmi; Aamir Ali Syed
Journal:  World J Surg       Date:  2014-10       Impact factor: 3.352

6.  Redefining resection margin status in pancreatic cancer.

Authors:  Caroline S Verbeke; Krishna V Menon
Journal:  HPB (Oxford)       Date:  2009-06       Impact factor: 3.647

7.  Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP).

Authors:  Krishna V Menon; Dhanwant Gomez; Andrew M Smith; Alan Anthoney; Caroline S Verbeke
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

Review 8.  Ductal pancreatic adenocarcinoma.

Authors:  Thomas Seufferlein; Marc Porzner; Volker Heinemann; Andrea Tannapfel; Martin Stuschke; Waldemar Uhl
Journal:  Dtsch Arztebl Int       Date:  2014-05-30       Impact factor: 5.594

9.  En bloc vascular resection for the treatment of borderline resectable pancreatic head carcinoma.

Authors:  Hirohisa Kitagawa; Hidehiro Tajima; Hisatoshi Nakagawara; Isamu Makino; Tomoharu Miyashita; Masatoshi Shoji; Shinichi Nakanuma; Norihiro Hayashi; Hiroyuki Takamura; Tetsuo Ohta; Hiroshi Ohtake
Journal:  Mol Clin Oncol       Date:  2014-02-27

10.  Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head.

Authors:  Quentin Denost; Christophe Laurent; Jean-Philippe Adam; Maylis Capdepont; Veronique Vendrely; Denis Collet; Antonio Sa Cunha
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.